Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up‐regulated modulator of apoptosis (Puma) in a model of Parkinson’s disease-Reference-Cited by-同舟云学术

Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up‐regulated modulator of apoptosis (Puma) in a model of Parkinson’s disease

Published:2020-02-05 Issue:5 Volume:154 Page:547-561
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Sanphui Priyankar¹,Kumar Das Anoy¹,Biswas Subhas C.¹^ORCID

Affiliation:

1. Cell Biology and Physiology Division CSIR‐Indian Institute of Chemical Biology Kolkata India

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14969

Reference61 articles.

1. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models

2. The Essential Role of p53-up-regulated Modulator of Apoptosis (Puma) and Its Regulation by FoxO3a Transcription Factor in β-Amyloid-induced Neuron Death

3. 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

4. Puma and p53 Play Required Roles in Death Evoked in a Cellular Model of Parkinson Disease

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible involvement of NAMPT in neuronal survival in cerebral ischemic injury under high-glucose conditions through the FoxO3a/LC3 pathway;Biomedicine & Pharmacotherapy;2024-07

2. The role of Foxo3a in neuron-mediated cognitive impairment;Frontiers in Molecular Neuroscience;2024-06-19

3. Cdc25A phosphatase is activated and mediates neuronal cell death by PUMA via pRB/E2F1 pathway in a model of Parkinson’s disease;2024-05-07

4. Alpha‐synuclein promotes PRMT5‐mediated H4R3me2s histone methylation by interacting with the BAF complex;The FEBS Journal;2023-12-26

5. The common denominators of Parkinson’s disease pathogenesis and methamphetamine abuse;Current Neuropharmacology;2023-09-07